drugset / Trial / NCT04349371

Saved From COVID-19 - Chloroquine (CQ) Prophylaxis for Health Care Workers at Risk for COVID

NCT04349371

Phase 2 Terminated 5 enrolled Columbia University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The primary objective is to determine the clinical efficacy of Chloroquine (CQ) in health care workers with moderate to high risk of exposure to COVID-19 in preventing symptomatic COVID-19 infections. Secondary endpoints will explore the efficacy of CQ in preventing any infection as defined by seroconversion to positive anti-COVID antibody status.

Timeline

Start
2020-04-21
Primary completion
2021-02-11
Completion
2021-02-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Chloroquine Small molecule 250 mg Oral
Subject Chloroquine Small molecule 500 mg Oral

Indications